Total Payments
$15,514
2024 Payments
$1,433
Companies
52
Transactions
852
Medicare Patients
2,293
Medicare Billing
$384,965
Payment Breakdown by Category
Food & Beverage$15,211 (98.0%)
Other$242.59 (1.6%)
Gifts$39.39 (0.3%)
Education$20.72 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,211 | 839 | 98.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $242.59 | 8 | 1.6% |
| Gift | $39.39 | 3 | 0.3% |
| Education | $20.72 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,391 | 82 | $0 (2024) |
| Biogen, Inc. | $1,034 | 66 | $0 (2024) |
| Allergan, Inc. | $988.04 | 81 | $0 (2022) |
| Eisai Inc. | $977.87 | 54 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $960.20 | 59 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $939.80 | 47 | $0 (2023) |
| Grifols USA, LLC | $730.38 | 40 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $625.91 | 46 | $0 (2022) |
| GENZYME CORPORATION | $622.66 | 20 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $577.41 | 25 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,433 | 63 | ABBVIE INC. ($316.66) |
| 2023 | $1,608 | 70 | AbbVie Inc. ($503.97) |
| 2022 | $1,103 | 45 | ABBVIE INC. ($234.16) |
| 2021 | $909.52 | 49 | AbbVie Inc. ($290.95) |
| 2020 | $602.32 | 41 | Allergan, Inc. ($190.88) |
| 2019 | $2,292 | 104 | EISAI INC. ($330.36) |
| 2018 | $3,854 | 256 | Novartis Pharmaceuticals Corporation ($414.62) |
| 2017 | $3,711 | 224 | Biogen, Inc. ($501.30) |
All Payment Transactions
852 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 12/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.05 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/02/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $68.74 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.50 | General |
| 11/21/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Neuropsychiatry | ||||||
| 10/28/2024 | SCILEX PHARMACEUTICALS INC. | ELYXYB - CELECOXIB (Drug) | Food and Beverage | In-kind items and services | $51.01 | General |
| Category: Pain Management | ||||||
| 10/28/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 10/28/2024 | SCILEX PHARMACEUTICALS INC. | ELYXYB - CELECOXIB (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Pain Management | ||||||
| 10/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/09/2024 | Biogen, Inc. | QALSODY (Drug), SKYCLARYS | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Neurology | ||||||
| 08/16/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Neurology | ||||||
| 08/09/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.98 | General |
| 08/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/01/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $30.35 | General |
| 07/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Immunology and Neurology | ||||||
| 07/09/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $29.68 | General |
| Category: NEUROLOGY | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $27.58 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 723 | 933 | $475,121 | $121,241 |
| 2022 | 13 | 565 | 767 | $382,597 | $98,948 |
| 2021 | 12 | 520 | 706 | $340,739 | $92,201 |
| 2020 | 12 | 485 | 668 | $302,450 | $72,575 |
Total Patients
2,293
Total Services
3,074
Medicare Billing
$384,965
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 160 | 227 | $126,439 | $36,343 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 132 | 165 | $67,815 | $18,786 | 27.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 55 | 111 | $39,072 | $10,279 | 26.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 48 | 48 | $38,256 | $8,869 | 23.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 49 | 56 | $43,176 | $8,554 | 19.8% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 27 | 28 | $31,612 | $7,312 | 23.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 50 | 51 | $26,622 | $6,242 | 23.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 54 | $21,276 | $5,892 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 42 | $26,670 | $5,539 | 20.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 53 | 71 | $19,383 | $5,176 | 26.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 25 | 25 | $22,425 | $4,825 | 21.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 33 | $9,141 | $2,432 | 26.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 22 | $3,234 | $990.78 | 30.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 115 | 165 | $91,905 | $27,866 | 30.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 86 | 113 | $46,443 | $13,692 | 29.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 41 | 84 | $33,096 | $7,873 | 23.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 41 | 43 | $33,153 | $7,629 | 23.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 29 | 64 | $22,528 | $6,314 | 28.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $23,910 | $6,292 | 26.3% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 21 | 21 | $23,709 | $5,913 | 24.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 50 | 83 | $22,659 | $5,601 | 24.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 41 | 46 | $25,622 | $4,239 | 16.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 30 | 30 | $15,660 | $3,665 | 23.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $13,970 | $3,426 | 24.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 12 | 15 | $15,885 | $2,985 | 18.8% |
About Dr. Adina Alport, MD
Dr. Adina Alport, MD is a Neurology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265401400.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adina Alport, MD has received a total of $15,514 in payments from pharmaceutical and medical device companies, with $1,433 received in 2024. These payments were reported across 852 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($15,211).
As a Medicare-enrolled provider, Alport has provided services to 2,293 Medicare beneficiaries, totaling 3,074 services with total Medicare billing of $384,965. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Brooklyn, NY
- Active Since 03/17/2006
- Last Updated 04/19/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265401400
Products in Payments
- NUPLAZID (Drug) $939.80
- Fycompa (Drug) $889.98
- BOTOX (Biological) $806.90
- Gamunex-C (Biological) $730.38
- UBRELVY (Drug) $569.27
- TYSABRI (Biological) $532.29
- APTIOM (Drug) $468.79
- NUEDEXTA (Drug) $424.64
- ACTHAR (Biological) $412.50
- Austedo XR (Drug) $398.34
- RYTARY (Drug) $398.29
- Rebif (Biological) $383.32
- QULIPTA (Drug) $346.49
- AUBAGIO (Drug) $321.18
- Xadago (Drug) $294.81
- SOLIRIS (Drug) $284.00
- GILENYA (Drug) $253.37
- Neupro (Drug) $248.85
- NORTHERA (Drug) $240.54
- LEMTRADA (Drug) $226.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Brooklyn
Karen Blitz-Shabbir, Do, DO
Neurology — Payments: $393,441
Neurology $393,441
Miss. Larisa Syrow, Md, MD
Neurology — Payments: $182,526
Neurology $182,526
Nada Abou-Fayssal, Md, MD
Neurology — Payments: $126,065
Neurology $126,065
Robyn Wolintz, Md, MD
Neurology — Payments: $123,772
Neurology $123,772
Miran Salgado, Md, MD
Neurology — Payments: $101,072
Neurology $101,072
Dr. Dmitriy Grinshpun, M.d, M.D
Neurology — Payments: $96,680
Neurology $96,680